| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CBIN.10696 |
| P698 | PubMed publication ID | 27778412 |
| P2093 | author name string | Hang Wang | |
| Xiaoyu Li | |||
| Yuanyuan Ma | |||
| Ke Yu | |||
| Jiefei Shen | |||
| Xiangnan Wu | |||
| Xianxian Li | |||
| Wenjia Liu | |||
| P2860 | cites work | Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway | Q24305237 |
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Bone resorption by osteoclasts | Q28145169 | ||
| Evidence for osteocyte regulation of bone homeostasis through RANKL expression | Q28247757 | ||
| Transcriptional regulation by the MAP kinase signaling cascades | Q28679148 | ||
| Transcriptional responses to polypeptide ligands: the JAK-STAT pathway | Q29620287 | ||
| Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors | Q32024958 | ||
| Osteonecrosis induced by a single administration of low-dose lipopolysaccharide in rabbits | Q33337844 | ||
| Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis | Q33877602 | ||
| Physiological functions of osteoblast lineage and T cell-derived RANKL in bone homeostasis | Q34369482 | ||
| Cytokine production in whole blood cell cultures of patients with rheumatoid arthritis | Q35546993 | ||
| IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology | Q35640443 | ||
| Mechanosensation and Transduction in Osteocytes | Q35741903 | ||
| Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations | Q36005508 | ||
| Osteocyte RANKL: new insights into the control of bone remodeling | Q36253514 | ||
| Immune response: the key to bone resorption in periodontal disease | Q36309235 | ||
| Osteoblast Lineage Cells Play an Essential Role in Periodontal Bone Loss Through Activation of Nuclear Factor-Kappa B | Q36370991 | ||
| The role of the interleukin-6/gp130 signaling pathway in bone metabolism | Q36617113 | ||
| Functions of RANKL/RANK/OPG in bone modeling and remodeling | Q36700779 | ||
| Regulation of cortical and trabecular bone mass by communication between osteoblasts, osteocytes and osteoclasts | Q38215896 | ||
| RANKL/OPG; Critical role in bone physiology. | Q38306944 | ||
| Glutathione, N-acetylcysteine and lipoic acid down-regulate starvation-induced apoptosis, RANKL/OPG ratio and sclerostin in osteocytes: involvement of JNK and ERK1/2 signalling | Q38912068 | ||
| Concomitant activation of the PI3K/Akt and ERK1/2 signalling is involved in cyclic compressive force-induced IL-6 secretion in MLO-Y4 cells | Q39038707 | ||
| Serotonin acts as a novel regulator of interleukin-6 secretion in osteocytes through the activation of the 5-HT(2B) receptor and the ERK1/2 signalling pathway | Q39065170 | ||
| Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue | Q39475508 | ||
| ERK1/2 is involved in cyclic compressive force-induced IL-6 secretion in MLO-Y4 cells | Q39654612 | ||
| Gene expression patterns of osteocyte-like MLO-Y4 cells in response to cyclic compressive force stimulation | Q39756270 | ||
| Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system. | Q40477297 | ||
| STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroi | Q40945774 | ||
| Defective nuclear factor-κB-inducing kinase in aly/aly mice prevents bone resorption induced by local injection of lipopolysaccharide. | Q42484433 | ||
| Transcriptional control of receptor activator of nuclear factor-kappaB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers | Q42503028 | ||
| IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae | Q44129538 | ||
| Locally administered T cells from mice immunized with lipopolysaccharide (LPS) accelerate LPS-induced bone resorption | Q47814012 | ||
| P433 | issue | 1 | |
| P921 | main subject | lipopolysaccharide | Q421804 |
| P304 | page(s) | 84-92 | |
| P577 | publication date | 2016-10-24 | |
| P1433 | published in | Cell Biology International | Q1254690 |
| P1476 | title | Lipopolysaccharide increases IL-6 secretion via activation of the ERK1/2 signaling pathway to up-regulate RANKL gene expression in MLO-Y4 cells. | |
| P478 | volume | 41 |
| Q64275098 | Bone function, dysfunction and its role in diseases including critical illness |
| Q28817148 | Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease |
| Q90152411 | S100A9 Increases IL-6 and RANKL Expressions through MAPKs and STAT3 Signaling Pathways in Osteocyte-Like Cells |
| Q64106454 | The Osteocyte as a Novel Key Player in Understanding Periodontitis Through its Expression of RANKL and Sclerostin: a Review |
| Q47132574 | Tumor Acidosis and Hypoxia Differently Modulate the Inflammatory Program: Measurements In Vitro and In Vivo |
Search more.